-
1
-
-
80051947010
-
Safety of antitumour necrosis factor agents in patients with chronic hepatitis C infection: A systematic review
-
Brunasso AM, Puntoni M, Gulia A, Massone C. Safety of antitumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review. Rheumatology (Oxford). 2011;50(9):1700-11.
-
(2011)
Rheumatology (Oxford)
, vol.50
, Issue.9
, pp. 1700-1711
-
-
Brunasso, A.M.1
Puntoni, M.2
Gulia, A.3
Massone, C.4
-
2
-
-
0142182744
-
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
-
Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology. 2003;38(5):1282-8.
-
(2003)
Hepatology
, vol.38
, Issue.5
, pp. 1282-1288
-
-
Watashi, K.1
Hijikata, M.2
Hosaka, M.3
Yamaji, M.4
Shimotohno, K.5
-
3
-
-
25844523297
-
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
-
Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-73.
-
(2005)
Hepatology
, vol.42
, Issue.4
, pp. 962-973
-
-
Simmonds, P.1
Bukh, J.2
Combet, C.3
Deleage, G.4
Enomoto, N.5
Feinstone, S.6
-
4
-
-
71649088247
-
Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation
-
Frankel AJ, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF, Jr., et al. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;61(6):1044-55.
-
(2009)
J Am Acad Dermatol
, vol.61
, Issue.6
, pp. 1044-1055
-
-
Frankel, A.J.1
van Voorhees, A.S.2
Hsu, S.3
Korman, N.J.4
Lebwohl, M.G.5
Bebo Jr., B.F.6
-
5
-
-
33747165641
-
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients
-
Galeazzi M, Bellisai F, Manganelli S, Morozzi G, Sebastiani GD. Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients. Autoimmun Rev. 2006;5(7):493-8.
-
(2006)
Autoimmun Rev
, vol.5
, Issue.7
, pp. 493-498
-
-
Galeazzi, M.1
Bellisai, F.2
Manganelli, S.3
Morozzi, G.4
Sebastiani, G.D.5
-
6
-
-
34447318385
-
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
-
Shiffman ML, Suter F, Bacon BR, Nelson D, Harley H, Sola R, et al. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl J Med. 2007;357(2):124-34.
-
(2007)
N Engl J Med
, vol.357
, Issue.2
, pp. 124-134
-
-
Shiffman, M.L.1
Suter, F.2
Bacon, B.R.3
Nelson, D.4
Harley, H.5
Sola, R.6
-
7
-
-
44949164546
-
Extensive psoriasis induced by pegylated interferon: A case report
-
Citro V, Fristachi R, Tarantino G. Extensive psoriasis induced by pegylated interferon: a case report. J Med Case Reports. 2007;1:86.
-
(2007)
J Med Case Reports
, vol.1
, pp. 86
-
-
Citro, V.1
Fristachi, R.2
Tarantino, G.3
-
8
-
-
34447102149
-
Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C
-
Imafuku S, Tashiro A, Furue M. Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C. Br J Dermatol. 2007;156(6):1367-9.
-
(2007)
Br J Dermatol
, vol.156
, Issue.6
, pp. 1367-1369
-
-
Imafuku, S.1
Tashiro, A.2
Furue, M.3
-
9
-
-
70249137988
-
European S3-guidelines on the systemic treatment of psoriasis vulgaris
-
Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23 (2):1-70.
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, Issue.2
, pp. 1-70
-
-
Pathirana, D.1
Ormerod, A.D.2
Saiag, P.3
Smith, C.4
Spuls, P.I.5
Nast, A.6
-
10
-
-
77955283318
-
Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: Risk or opportunity?
-
Di Lernia V, Albertini G. Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity? J Am Acad Dermatol. 2010;63(2):342-3.
-
(2010)
J Am Acad Dermatol
, vol.63
, Issue.2
, pp. 342-343
-
-
Di Lernia, V.1
Albertini, G.2
-
11
-
-
10744223246
-
Specific inhibition of hepatitis C virus replication by cyclosporin A
-
Nakagawa M, Sakamoto N, Enomoto N, Tanabe Y, Kanazawa N, Koyama T, et al. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem Biophys Res Commun. 2004;313(1):42-7.
-
(2004)
Biochem Biophys Res Commun
, vol.313
, Issue.1
, pp. 42-47
-
-
Nakagawa, M.1
Sakamoto, N.2
Enomoto, N.3
Tanabe, Y.4
Kanazawa, N.5
Koyama, T.6
-
12
-
-
33646194456
-
Diverse effects of cyclosporine on hepatitis C virus strain replication
-
Ishii N, Watashi K, Hishiki T, Goto K, Inoue D, Hijikata M, et al. Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol. 2006;80(9):4510-20.
-
(2006)
J Virol
, vol.80
, Issue.9
, pp. 4510-4520
-
-
Ishii, N.1
Watashi, K.2
Hishiki, T.3
Goto, K.4
Inoue, D.5
Hijikata, M.6
-
13
-
-
43949123575
-
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
-
Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R, Tang H. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro. J Virol. 2008;82(11):5269-78.
-
(2008)
J Virol
, vol.82
, Issue.11
, pp. 5269-5278
-
-
Yang, F.1
Robotham, J.M.2
Nelson, H.B.3
Irsigler, A.4
Kenworthy, R.5
Tang, H.6
-
14
-
-
33846238124
-
Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysis
-
Berenguer M, Royuela A, Zamora J. Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis. Liver Transpl. 2007;13(1):21-9.
-
(2007)
Liver Transpl
, vol.13
, Issue.1
, pp. 21-29
-
-
Berenguer, M.1
Royuela, A.2
Zamora, J.3
-
15
-
-
17844375433
-
Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease
-
Inoue K, Yoshiba M. Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease. Transplant Proc. 2005;37(2):1233-4.
-
(2005)
Transplant Proc
, vol.37
, Issue.2
, pp. 1233-1234
-
-
Inoue, K.1
Yoshiba, M.2
-
16
-
-
20044366379
-
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy
-
Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol. 2005;76(3):327-32.
-
(2005)
J Med Virol
, vol.76
, Issue.3
, pp. 327-332
-
-
Ansaldi, F.1
Bruzzone, B.2
Salmaso, S.3
Rota, M.C.4
Durando, P.5
Gasparini, R.6
|